1. Home
  2. BHVN vs CENT Comparison

BHVN vs CENT Comparison

Compare BHVN & CENT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • CENT
  • Stock Information
  • Founded
  • BHVN 2013
  • CENT 1955
  • Country
  • BHVN United States
  • CENT United States
  • Employees
  • BHVN N/A
  • CENT N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • CENT Consumer Specialties
  • Sector
  • BHVN Health Care
  • CENT Consumer Discretionary
  • Exchange
  • BHVN Nasdaq
  • CENT Nasdaq
  • Market Cap
  • BHVN 1.9B
  • CENT 2.4B
  • IPO Year
  • BHVN 2017
  • CENT N/A
  • Fundamental
  • Price
  • BHVN $20.25
  • CENT $34.59
  • Analyst Decision
  • BHVN Strong Buy
  • CENT Strong Buy
  • Analyst Count
  • BHVN 14
  • CENT 3
  • Target Price
  • BHVN $62.92
  • CENT $45.00
  • AVG Volume (30 Days)
  • BHVN 2.2M
  • CENT 127.3K
  • Earning Date
  • BHVN 05-16-2025
  • CENT 05-07-2025
  • Dividend Yield
  • BHVN N/A
  • CENT N/A
  • EPS Growth
  • BHVN N/A
  • CENT N/A
  • EPS
  • BHVN N/A
  • CENT 1.87
  • Revenue
  • BHVN N/A
  • CENT $3,155,810,000.00
  • Revenue This Year
  • BHVN N/A
  • CENT $2.74
  • Revenue Next Year
  • BHVN $65.26
  • CENT $2.16
  • P/E Ratio
  • BHVN N/A
  • CENT $18.39
  • Revenue Growth
  • BHVN N/A
  • CENT N/A
  • 52 Week Low
  • BHVN $15.79
  • CENT $32.16
  • 52 Week High
  • BHVN $55.70
  • CENT $47.48
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 43.84
  • CENT 46.93
  • Support Level
  • BHVN $18.99
  • CENT $32.16
  • Resistance Level
  • BHVN $24.06
  • CENT $35.37
  • Average True Range (ATR)
  • BHVN 2.03
  • CENT 1.14
  • MACD
  • BHVN 0.24
  • CENT 0.03
  • Stochastic Oscillator
  • BHVN 42.62
  • CENT 63.75

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About CENT Central Garden & Pet Company

Central Garden & Pet Co understands that home is central to life and has nurtured happy and healthy homes for over forty years. The segments of the company are the pet segment and garden segment. The company's trusted products are dedicated to helping lawns grow greener, gardens bloom bigger, pets live healthier and communities grow stronger. Central is home to a portfolio of more than sixty-five brands including Pennington, Nylabone, Kaytee, Amdro, and Aqueon, manufacturing and distribution capabilities, and a passionate, entrepreneurial growth culture. Central Garden and Pet is based in Walnut Creek, California, and has offices across North America and Europe.

Share on Social Networks: